Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

por Ito, Y, Takeda, T, Sakon, M, Tsujimoto, M, Higashiyama, S, Noda, K, Miyoshi, E, Monden, M, Matsuura, N
Publicado 2001

Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma

por Ito, Y, Matsuura, N, Sakon, M, Takeda, T, Umeshita, K, Nagano, H, Nakamori, S, Dono, K, Tsujimoto, M, Nakahara, M, Nakao, K, Monden, M
Publicado 1999

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma

por Ito, Y, Monden, M, Takeda, T, Eguchi, H, Umeshita, K, Nagano, H, Nakamori, S, Dono, K, Sakon, M, Nakamura, M, Tsujimoto, M, Nakahara, M, Nakao, K, Yokosaki, Y, Matsuura, N
Publicado 2000

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interfe...

por Ota, H, Nagano, H, Sakon, M, Eguchi, H, Kondo, M, Yamamoto, T, Nakamura, M, Damdinsuren, B, Wada, H, Marubashi, S, Miyamoto, A, Dono, K, Umeshita, K, Nakamori, S, Wakasa, K, Monden, M
Publicado 2005